Nutriband Inc. (NASDAQ: NTRB) is a Healthcare company (Biotechnology) with a market capitalization of $68M. The Maz Rating grades it against the other companies in its sector.
Nutriband Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $5.59, Nutriband Inc. trades at 42.2x sales and 12.8x book value. Over the last twelve months it generated about $2M of revenue and a net loss of $7M. It runs a gross margin of 33.1%, an operating margin of -435.6% and a net margin of -430.4%. It shows return on equity of -109.0%, return on invested capital of -127.0% and a free cash flow yield of -5.3%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 4.21. Over the past 52 weeks the share price ranged from $2.80 to $9.19, with a beta of 1.93.
Nutriband Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.